1997
DOI: 10.1523/jneurosci.17-19-07415.1997
|View full text |Cite
|
Sign up to set email alerts
|

Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury

Abstract: We examined the temporal profile of apoptosis after fluid percussion-induced traumatic brain injury (TBI) in rats and investigated the potential pathophysiological role of caspase-3-like proteases in this process. DNA fragmentation was observed in samples from injured cortex and hippocampus, but not from contralateral tissue, beginning 4 hr after TBI and continuing for at least 3 d. Double labeling of brain with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) and an antibod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

29
377
4
18

Year Published

1998
1998
2006
2006

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 549 publications
(428 citation statements)
references
References 79 publications
29
377
4
18
Order By: Relevance
“…Released cytochrome c engages with caspase-9 and apoptotic proteaseactivating factor-1 (Apaf-1) to form an 'apoptosome' that activates caspase-3 and results in cellular changes producing apoptotic cell death (Li et al, 1997;Zou et al, 1997). Several relatively selective caspase-3 inhibitors such as DEVD have been reported to be neuroprotective after experimental TBI, used primarily to target events downstream from cytochrome c release (Clark et al, 2000;Knoblach et al, 2004;Yakovlev et al, 1997). Fewer studies have tested the effects of less selective caspase inhibitors after TBI, which could be expected to have effects both upstream and downstream from cytochrome c release.…”
Section: Discussionmentioning
confidence: 99%
“…Released cytochrome c engages with caspase-9 and apoptotic proteaseactivating factor-1 (Apaf-1) to form an 'apoptosome' that activates caspase-3 and results in cellular changes producing apoptotic cell death (Li et al, 1997;Zou et al, 1997). Several relatively selective caspase-3 inhibitors such as DEVD have been reported to be neuroprotective after experimental TBI, used primarily to target events downstream from cytochrome c release (Clark et al, 2000;Knoblach et al, 2004;Yakovlev et al, 1997). Fewer studies have tested the effects of less selective caspase inhibitors after TBI, which could be expected to have effects both upstream and downstream from cytochrome c release.…”
Section: Discussionmentioning
confidence: 99%
“…Upregulation of caspase-3 mRNAs is reported in various in vivo models of apoptosis of the nervous system: brain injury and Huntingtin transgenic mice. 20,21 In addition to ubiquitous transcription factors, (i) caspase (3, 7, 8 and 9) gene transcription is directly regulated by E2F1 in proliferating cells (and probably by other E2F family members 22 ), (ii) in differentiating keratinocytes, Notch can also upregulate caspase-3 promoter activity. 23 In addition to the well-known posttransductional regulation of caspases, caspase gene transcription also seems tightly controlled during differentiation commitment and stress responses.…”
Section: Discussionmentioning
confidence: 99%
“…16,41,80,82 In particular, downstream caspase-3 has been shown to be important to neuronal development and injury by inducing fragmentation of nuclear DNA in vitro and in vivo. 83,114 Additional control of cell death/survival is provided by the mammalian antiapoptotic proteins Bcl-X L and Bcl-2. The latter was shown to be upregulated in injured white matter axons following SCI.…”
Section: Experimental Modelsmentioning
confidence: 99%